Editas Medicine Inc (NASDAQ:EDIT)

36.30
BATS BZX Real-Time Price
As of 11:06am ET
 +0.17 / +0.47%
Today’s Change
15.28
Today|||52-Week Range
45.02
+18.13%
Year-to-Date
No recent news for Editas Medicine Inc.

Today’s Trading

Previous close36.13
Today’s open36.11
Day’s range35.85 - 36.34
Volume5,137
Average volume (3 months)1,073,581
Market cap$1.7B
Data as of 11:06am ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+1.32%
Earnings growth (this year)+4.60%
Earnings growth (next 5 years)-2.31%
Revenue growth (last year)+126.80%
P/E ratioNM
Price/Sales90.26
Price/Book7.57

Competitors

 Today’s
change
Today’s
% change
MYOVMyovant Sciences Ltd-0.07-0.34%
FPRXFive Prime Therapeut...-0.20-1.17%
RTRXRetrophin Inc-0.26-0.84%
CRSPCRISPR Therapeutics ...-0.11-0.19%
Data as of 11:08am ET, 07/20/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$13.7M
Annual profit (last year)-$120.3M
Net profit margin-876.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Katrine S. Bosley
Chief Financial &
Accounting Officer
Andrew A. F. Hack
Corporate headquarters
Cambridge, Massachusetts

Forecasts